收藏切换
Discussion on the management and implementation of clinical research on foreign subjects in China
收藏切换
PDF
Xiao-hui LIU, Ke-xin LI, Wen-jing BAI, Juan WANG, Duan-duan CONG, Xiao-yu XU, Yue LIU, Wen-yuan QI, Wei XUE
Chinese Journal of New Drugs | 2023, 32(24) : 2540 - 2543
Less
收藏切换
Chinese Journal of New Drugs | 2023, 32(24): 2540-2543
Discussion on the management and implementation of clinical research on foreign subjects in China
Full
Xiao-hui LIU, Ke-xin LI, Wen-jing BAI, Juan WANG, Duan-duan CONG, Xiao-yu XU, Yue LIU, Wen-yuan QI, Wei XUE
Affiliations
  • Clinical Trial Center, Beijing Hospital/National Center of Gerontology/Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China
Published: 2023-12-30
Outline
收藏切换

With China's accession to ICH and implementing a series of ICH guidelines, the pharmaceutical innovation system of China has been in line with international standards and deeply integrated into the global innovation system, making overseas declaration data can be used in China's new drug marketing application. The ability of global synchronous investigation and registration has been largely improved along with these development. Clinical trials gradually need to involve healthy foreign subjects, especially those who need to be compared in the pharmacokinetic characteristics of different races in order to bridge the existing data abroad. What are the similarities and differences between the management process of clinical research on healthy foreign subjects and their Chinese counterparts? What factors should be paid attention to? This article takes a phase I clinical trial involving Caucasian subjects as an example to share and discuss the implementation and management experience of clinical studies involving foreign subjects to answer these questions.

clinical trial  /  caucasian subjects  /  subject management
Xiao-hui LIU, Ke-xin LI, Wen-jing BAI, Juan WANG, Duan-duan CONG, Xiao-yu XU, Yue LIU, Wen-yuan QI, Wei XUE. Discussion on the management and implementation of clinical research on foreign subjects in China[J]. Chinese Journal of New Drugs, 2023 , 32 (24) : 2540 -2543 .
Year 2023 volume 32 Issue 24
PDF
40
8
Cite this Article
BibTeX
Article Info
  • Online Date:2026-03-05
  • Published:2023-12-30
Article Data
Affiliations
History
  • Accepted:2023-04-20
Funding
Affiliations
    Clinical Trial Center, Beijing Hospital/National Center of Gerontology/Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100730, China
References
Share
https://castjournals.cast.org.cn/joweb/zgxyzz/EN/
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT